| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 680 | 2017 |
| The mammary gland iodide transporter is expressed during lactation and in breast cancer UH Tazebay, IL Wapnir, O Levy, O Dohan, LS Zuckier, Q Hua Zhao, ... Nature medicine 6 (8), 871-878, 2000 | 637 | 2000 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (5), 235-251, 2017 | 608 | 2017 |
| Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group TO Nielsen, SCY Leung, DL Rimm, A Dodson, B Acs, S Badve, C Denkert, ... JNCI: Journal of the National Cancer Institute 113 (7), 808-819, 2021 | 448 | 2021 |
| Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in … MV Dieci, N Radosevic-Robin, S Fineberg, G Van den Eynden, N Ternes, ... Seminars in cancer biology 52, 16-25, 2018 | 418* | 2018 |
| An international study to increase concordance in Ki67 scoring MYC Polley, SCY Leung, D Gao, MG Mastropasqua, LA Zabaglo, ... Modern pathology 28 (6), 778-786, 2015 | 286 | 2015 |
| Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma S Fineberg, PP Rosen American journal of clinical pathology 102 (6), 757-763, 1994 | 234 | 1994 |
| The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical … PI Gonzalez‐Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... The Journal of pathology 250 (5), 667-684, 2020 | 167 | 2020 |
| Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein M Janakiram, JM Chinai, S Fineberg, A Fiser, C Montagna, ... Clinical cancer research 21 (10), 2359-2366, 2015 | 153 | 2015 |
| Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration SCY Leung, TO Nielsen, L Zabaglo, I Arun, SS Badve, AL Bane, J Bartlett, ... NPJ breast Cancer 2 (1), 1-9, 2016 | 143 | 2016 |
| The tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group K El Bairi, HR Haynes, E Blackley, S Fineberg, J Shear, S Turner, ... NPJ breast cancer 7 (1), 150, 2021 | 139 | 2021 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 131 | 2020 |
| Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group M Amgad, ES Stovgaard, E Balslev, J Thagaard, W Chen, S Dudgeon, ... NPJ breast cancer 6 (1), 16, 2020 | 121 | 2020 |
| Hsa‐miR‐375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity O Giricz, PA Reynolds, A Ramnauth, C Liu, T Wang, L Stead, G Childs, ... The Journal of pathology 226 (1), 108-119, 2012 | 91 | 2012 |
| Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer JA Sparano, S Moulder, A Kazi, D Coppola, A Negassa, L Vahdat, T Li, ... Clinical Cancer Research 15 (8), 2942-2948, 2009 | 86 | 2009 |
| Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration SCY Leung, TO Nielsen, LA Zabaglo, I Arun, SS Badve, AL Bane, ... Histopathology 75 (2), 225-235, 2019 | 85 | 2019 |
| Effective DNA/RNA co-extraction for analysis of microRNAs, mRNAs, and genomic DNA from formalin-fixed paraffin-embedded specimens A Kotorashvili, A Ramnauth, C Liu, J Lin, K Ye, R Kim, R Hazan, T Rohan, ... PloS one 7 (4), e34683, 2012 | 82 | 2012 |
| Pseudoangiomatous stromal hyperplasia of the breast: sonographic features with histopathologic correlation CL Mercado, SA Naidrich, D Hamele‐Bena, SA Fineberg, SS Buchbinder The Breast Journal 10 (5), 427-432, 2004 | 78 | 2004 |
| A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer Y Tu, DL Hershman, K Bhalla, W Fiskus, CM Pellegrino, E Andreopoulou, ... Breast cancer research and treatment 146, 145-152, 2014 | 69 | 2014 |
| Can features evaluated in the routine pathologic assessment of lymph node–negative estrogen receptor–positive stage I or II invasive breast cancer be used to predict the … J Auerbach, M Kim, S Fineberg Archives of Pathology and Laboratory Medicine 134 (11), 1697-1701, 2010 | 68 | 2010 |
